LGND
Ligand Pharmaceuticals Incorporated
303.00$
+0.1%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.89 | 1.59 | 1.71 | 2.30 | 2.81 | 2.26 | 2.36 | 2.39 | 5.72 | 2.82 | 2.60 | 2.92 | 13.31 | |
| 0.20 | 0.09 | 0.61 | -0.85 | 0.68 | 0.15 | 0.25 | 0.15 | 1.23 | -1.23 | 0.10 | 0.15 | 0.19 | |
| 1.69 | 1.50 | 1.10 | 3.15 | 2.13 | 2.11 | 2.11 | 2.24 | 4.49 | 4.05 | 2.50 | 2.77 | 13.12 | |
| 0.32 | 0.31 | 0.33 | 0.30 | 0.31 | 0.23 | 2.61 | 0.33 | 1.04 | 0.17 | 0.11 | 0.67 | 1.89 | |
| 0.84 | 0.90 | 0.60 | 0.98 | 1.33 | 1.35 | 0.98 | 1.01 | 1.41 | 1.18 | 1.05 | 1.33 | 4.74 | |
| 1.51 | 1.69 | 0.93 | 4.21 | 1.96 | 2.61 | 4.00 | 1.82 | 1.77 | 3.10 | 1.62 | 2.38 | 8.49 | |
| 0.18 | -0.19 | 0.16 | -1.06 | 0.17 | -0.51 | -1.89 | 0.42 | 2.72 | 0.95 | 0.87 | 0.39 | 4.62 | |
| 0.00 | 0.01 | 0.01 | 0.07 | 0.04 | 0.05 | 0.05 | 0.06 | 0.05 | 0.08 | 0.09 | 0.08 | 0.28 | |
| -0.70 | 0.97 | 6.26 | -3.63 | -0.34 | -2.07 | -2.61 | 0.56 | 7.00 | 2.69 | -1.22 | 2.94 | 10.90 | |
| -0.11 | -0.06 | 1.51 | -0.75 | 0.05 | -0.43 | -0.40 | 0.32 | 1.18 | 0.57 | -0.55 | 0.72 | 1.87 | |
| -0.59 | 1.03 | 4.75 | -2.88 | -0.39 | -1.64 | -2.21 | 0.24 | 5.81 | 2.12 | -0.67 | 2.22 | 9.03 | |
| -0.20 | 1.48 | 6.75 | -3.07 | 0.18 | -1.56 | -2.11 | 1.05 | 7.40 | 3.14 | -0.72 | 3.32 | 12.54 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.